A
Agata Bielecka-Dabrowa
Researcher at Medical University of Łódź
Publications - 69
Citations - 1180
Agata Bielecka-Dabrowa is an academic researcher from Medical University of Łódź. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 19, co-authored 50 publications receiving 937 citations. Previous affiliations of Agata Bielecka-Dabrowa include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
The mechanisms of atrial fibrillation in hyperthyroidism.
TL;DR: Atrial fibrillation is a complex condition with several possible contributing factors and several potential mechanisms could be invoked for the effect of thyroid hormones on AF risk, including elevation of left atrial pressure secondary to increased left ventricular mass and impaired ventricular relaxation.
Journal ArticleDOI
Takotsubo cardiomyopathy--the current state of knowledge.
Agata Bielecka-Dabrowa,Dimitri P. Mikhailidis,Simon Hannam,Jacek Rysz,Marta Michalska,Yoshihiro J. Akashi,Maciej Banach +6 more
TL;DR: The temporal relationship between the stressful event and the triggering of the clinical syndrome as well as the report of elevated catecholamine plasma levels during the acute phase suggest a possible involvement of the sympathetic nervous system.
Journal ArticleDOI
Cachexia, muscle wasting, and frailty in cardiovascular disease.
Agata Bielecka-Dabrowa,Agata Bielecka-Dabrowa,Nicole Ebner,Marcelo Rodrigues dos Santos,Junishi Ishida,Gerd Hasenfuss,Stephan von Haehling +6 more
TL;DR: An overview of the available knowledge of body wasting and physical frailty in patients with cardiovascular illness, particularly focussing on patients with heart failure, is provided, and mechanisms of wasting and possible therapeutic targets are discussed.
Journal Article
The role of polyphenols in cardiovascular disease
Marta Michalska,Anna Gluba,Dimitri P. Mikhailidis,Piotr Jan Nowak,Agata Bielecka-Dabrowa,Jacek Rysz,Maciej Banach +6 more
TL;DR: Dietary polyphenols, acting at the molecular level, improve endothelial function and inhibit platelet aggregation, and in view of their antithrombotic, anti-inflammatory, and anti-aggregative properties, these compounds may play a roles in the prevention and treatment of cardiovascular disease.
Journal ArticleDOI
The meaning of hypokalemia in heart failure
Agata Bielecka-Dabrowa,Dimitri P. Mikhailidis,Linda G. Jones,Jacek Rysz,Wilbert S. Aronow,Maciej Banach +5 more
TL;DR: Mild hypokalemia may be corrected by the use of aldosterone receptor antagonists such as spironolactone or eplerenone, however, a more severe hypkalemia should preferably be corrected using K(+) supplement.